Most Australians are likely to experience some form of pigmentation at some point in their lives, also referred to as hyper pigmentation or sun damage.
A downfall of living Down Under is that skin is prone to pigmentation on hands, arms and décolletage, as well as areas of the face.
According to Research and Markets, the pigmentation disorders treatment market is expected to grow with a CAGR of 9.7% during the period from 2020 to 2025.
It cites the key factors propelling the growth of this market as rising up-gradation of lifestyle coupled with the increasing demand for skin lightening.
Additionally, it lists the increasing the aging population, increasing incidence of skin disorders, and growing disposable income as the few other factors as boosting the global pigmentation disorder treatment market.
One commonly held myth is that skin needs to be burnt in order to develop pigmentation, but this is far from the case.
The sun’s UVA and UVB constantly penetrate the skin and many people will develop pigmentation as a result of day-to-day activities, even if they’re not spending hours baking in the sun.
Pigmentation can manifest in a number of ways – including both freckles and dark marks – and while genetic, hormonal and environmental factors can play a part, most pigmentation is caused by sun exposure, which is why it’s such a common skin concern among Australians.
Pigmentation – whether it comes in the form of melasma, which may be caused by hormonal changes, age spots due to UV sun exposure or post inflammatory hyper pigmentation (PIH) which can occur after injury to the skin – is caused by melanin moving through the layers of the skin.
Topical therapy for treatment includes hydroquinone as a first-line agent, also with a retinoid for treatment of melasma.
John Plunkett’s Superfade is the only product in Australia containing hydroquinone, which dermatologist Dr Michelle Rodrigues refers to as “the gold standard in fading pigmentation”.
Those with mild pigmentation should opt for the Superfade Accelerator Serum, while anyone suffering from a more moderate case of pigmentation should use the SuperFade Face Treatment Cream, Dr Rodrigues advises.
The Superfade Accelerator Serum contains a powerful blend of BHA and AHAs including Ferulic Acid Cytovectors that delivers clinical results after 28 days of consistent application, while the Superfade Face Treatment Cream alongside each other will radically reduce the signs of more hyper-pigmentation, and is suitable for anyone with persistent dark spots and sun damage, says Plunketts Pharmaceuticals Brand Manager Allison Brown.
“While skin pigmentation may be a direct and common effect of living in Australia, there are ways to remedy this complaint without resorting to in-salon and clinical treatments,” Allison said.
“Including just one of the Superfade products into your daily skincare regime will deliver real and lasting results and help achieve even and flawless skin, whatever your age or skin type.”